Transactions
41
Insider / Medpace Holdings, Inc.
Troendle August J.
CEO at Medpace Holdings, Inc.
- Company
- Medpace Holdings, Inc.
- Ticker
- MEDP
- First filing on record
- November 14, 2025
- Latest trade on record
- September 30, 2026
- SEC filings
- EDGAR ↗
Troendle August J., CEO at Medpace Holdings, Inc., has disclosed 41 transactions in MEDP since November 14, 2025: 0 purchases (0 open-market buys) and 39 sales, worth about $358.5M at the reported prices. The latest was filed October 1, 2026, 1 day after the trade; 1 filing was late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
39
Avg. disclosure lag
2.1d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Troendle August J. made no purchases and 39 sales worth $358M, plus 2 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Troendle August J. has traded 1 stock on record; the largest by dollars is MEDP.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 22 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| S | Open-market sale | 39 | 586,377 | $358.5M |
| A | Grant or award | 2 | 30,000 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 26 | 0 | 24 · $190.9M |
| 2025 | 15 | 0 | 15 · $167.6M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| MEDP | Sell S | September 30, 2026 | October 1, 2026 | 1d | 21,966 | $625 | $13.7M | Form 4 ↗ | ||
| MEDP | Sell S | September 29, 2026 | October 1, 2026 | 2d | 26,701 | $621 | $16.6M | Form 4 ↗ | ||
| MEDP | Sell S | September 28, 2026 | September 29, 2026 | 1d | 2,410 | $620 | $1.5M | Form 4 ↗ | ||
| MEDP | Sell S | September 25, 2026 | September 29, 2026 | 4d | 154 | $621 | $96K | Form 4 ↗ | ||
| MEDP | Sell S | September 24, 2026 | September 25, 2026 | 1d | 27,833 | $621 | $17.3M | Form 4 ↗ | ||
| MEDP | Sell S | September 23, 2026 | September 25, 2026 | 2d | 16,083 | $629 | $10.1M | Form 4 ↗ | ||
| MEDP | Sell S | September 22, 2026 | September 23, 2026 | 1d | 49,018 | $628 | $30.8M | Form 4 ↗ | ||
| MEDP | Sell S | September 21, 2026 | September 23, 2026 | 2d | 21,883 | $623 | $13.6M | Form 4 ↗ | ||
| MEDP | Sell S | September 17, 2026 | September 21, 2026 | 4d | 10,880 | $620 | $6.7M | Form 4 ↗ | ||
| MEDP | Sell S | September 16, 2026 | September 17, 2026 | 1d | 8,770 | $621 | $5.4M | Form 4 ↗ | ||
| MEDP | Sell S | September 15, 2026 | September 17, 2026 | 2d | 15,971 | $621 | $9.9M | Form 4 ↗ | ||
| MEDP | Sell S | August 27, 2026 | August 31, 2026 | 4d | 650 | $620 | $403K | Form 4 ↗ | ||
| MEDP | Sell S | August 26, 2026 | August 27, 2026 | 1d | 4,000 | $620 | $2.5M | Form 4 ↗ | ||
| MEDP | Sell S | August 25, 2026 | August 27, 2026 | 2d | 673 | $620 | $418K | Form 4 ↗ | ||
| MEDP | Sell S | August 24, 2026 | August 25, 2026 | 1d | 1,983 | $620 | $1.2M | Form 4 ↗ | ||
| MEDP | Sell S | August 21, 2026 | August 25, 2026 | 4d | 13,995 | $624 | $8.7M | Form 4 ↗ | ||
| MEDP | Sell S | August 20, 2026 | August 21, 2026 | 1d | 27,174 | $619 | $16.8M | Form 4 ↗ | ||
| MEDP | Sell S | August 19, 2026 | August 21, 2026 | 2d | 15,609 | $606 | $9.5M | Form 4 ↗ | ||
| MEDP | Sell S | August 13, 2026 | August 14, 2026 | 1d | 458 | $600 | $275K | Form 4 ↗ | ||
| MEDP | Sell S | August 12, 2026 | August 14, 2026 | 2d | 11,366 | $602 | $6.8M | Form 4 ↗ | ||
| MEDP | Sell S | August 11, 2026 | August 12, 2026 | 1d | 17,610 | $605 | $10.7M | Form 4 ↗ | ||
| MEDP | Sell S | August 10, 2026 | August 12, 2026 | 2d | 5,534 | $602 | $3.3M | Form 4 ↗ | ||
| MEDP | Sell S | July 28, 2026 | July 29, 2026 | 1d | 3,510 | $600 | $2.1M | Form 4 ↗ | ||
| MEDP | Sell S | July 27, 2026 | July 29, 2026 | 2d | 3,728 | $601 | $2.2M | Form 4 ↗ | ||
| MEDP | Other A | April 24, 2026 | April 28, 2026 | 4d | 10,000 | — | — | derivative | Form 4 ↗ | |
| MEDP | Other A | April 24, 2026 | April 28, 2026 | 4d | 20,000 | — | — | derivative | Form 4 ↗ | |
| MEDP | Sell S | December 3, 2025 | December 4, 2025 | 1d | 668 | $591 | $395K | Form 4 ↗ | ||
| MEDP | Sell S | December 2, 2025 | December 3, 2025 | 1d | 5,698 | $590 | $3.4M | Form 4 ↗ | ||
| MEDP | Sell S | December 1, 2025 | December 3, 2025 | 2d | 23,178 | $593 | $13.8M | Form 4 ↗ | ||
| MEDP | Sell S | November 28, 2025 | December 1, 2025 | 3d | 15,151 | $593 | $9.0M | Form 4 ↗ | ||
| MEDP | Sell S | November 26, 2025 | December 1, 2025 | 5d | 41,331 | $607 | $25.1M | late | Form 4 ↗ | |
| MEDP | Sell S | November 25, 2025 | November 26, 2025 | 1d | 42,392 | $616 | $26.1M | Form 4 ↗ | ||
| MEDP | Sell S | November 24, 2025 | November 26, 2025 | 2d | 59,025 | $608 | $35.9M | Form 4 ↗ | ||
| MEDP | Sell S | November 21, 2025 | November 24, 2025 | 3d | 21,858 | $592 | $12.9M | Form 4 ↗ | ||
| MEDP | Sell S | November 20, 2025 | November 24, 2025 | 4d | 6,830 | $598 | $4.1M | Form 4 ↗ | ||
| MEDP | Sell S | November 19, 2025 | November 20, 2025 | 1d | 23,862 | $592 | $14.1M | Form 4 ↗ | ||
| MEDP | Sell S | November 18, 2025 | November 20, 2025 | 2d | 7,191 | $591 | $4.2M | Form 4 ↗ | ||
| MEDP | Sell S | November 17, 2025 | November 18, 2025 | 1d | 6,047 | $591 | $3.6M | Form 4 ↗ | ||
| MEDP | Sell S | November 14, 2025 | November 18, 2025 | 4d | 14,747 | $595 | $8.8M | Form 4 ↗ | ||
| MEDP | Sell S | November 13, 2025 | November 14, 2025 | 1d | 5,128 | $601 | $3.1M | Form 4 ↗ | ||
| MEDP | Sell S | November 12, 2025 | November 14, 2025 | 2d | 5,312 | $603 | $3.2M | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 1, 2026 | Form 4 | 0001622058-26-000022 | 2 | published | EDGAR ↗ |
| September 29, 2026 | Form 4 | 0001622058-26-000020 | 2 | published | EDGAR ↗ |
| September 25, 2026 | Form 4 | 0001622058-26-000018 | 2 | published | EDGAR ↗ |
| September 23, 2026 | Form 4 | 0001622058-26-000016 | 2 | published | EDGAR ↗ |
| September 21, 2026 | Form 4 | 0001622058-26-000014 | 1 | published | EDGAR ↗ |
| September 17, 2026 | Form 4 | 0001622058-26-000012 | 2 | published | EDGAR ↗ |
| August 31, 2026 | Form 4 | 0001622058-26-000010 | 1 | published | EDGAR ↗ |
| August 27, 2026 | Form 4 | 0001622058-26-000008 | 2 | published | EDGAR ↗ |
| August 25, 2026 | Form 4 | 0000892251-26-000152 | 2 | published | EDGAR ↗ |
| August 21, 2026 | Form 4 | 0000892251-26-000125 | 2 | published | EDGAR ↗ |
| August 14, 2026 | Form 4 | 0000892251-26-000114 | 2 | published | EDGAR ↗ |
| August 12, 2026 | Form 4 | 0001622058-26-000006 | 2 | published | EDGAR ↗ |
| July 29, 2026 | Form 4 | 0001622058-26-000004 | 2 | published | EDGAR ↗ |
| April 28, 2026 | Form 4 | 0001622058-26-000002 | 2 | published | EDGAR ↗ |
| December 4, 2025 | Form 4 | 0001622058-25-000023 | 1 | published | EDGAR ↗ |
| December 3, 2025 | Form 4 | 0001622058-25-000021 | 2 | published | EDGAR ↗ |
| December 1, 2025 | Form 4 | 0001622058-25-000019 | 2 | published | EDGAR ↗ |
| November 26, 2025 | Form 4 | 0001622058-25-000017 | 2 | published | EDGAR ↗ |
| November 24, 2025 | Form 4 | 0001622058-25-000015 | 2 | published | EDGAR ↗ |
| November 20, 2025 | Form 4 | 0001622058-25-000013 | 2 | published | EDGAR ↗ |
| November 18, 2025 | Form 4 | 0001622058-25-000011 | 2 | published | EDGAR ↗ |
| November 14, 2025 | Form 4 | 0001622058-25-000009 | 2 | published | EDGAR ↗ |
Other insiders at Medpace Holdings, Inc.
- BURWIG SUSAN E Exec. VP, Operations 22 rows
- Kraft Robert O. Director 18 rows
- McCarthy Cornelius P. III Director 16 rows
- Carley Brian T Director 15 rows
- EWALD STEPHEN P General Counsel & Corp. Secy. 12 rows
- Brady Kevin M. CFO & Treasurer 11 rows
- DAVENPORT FRED B JR Director 11 rows
- GEIGER JESSE J President 10 rows
- Gwadry-Sridhar Femida H. Director 1 row
- Zander Dani S. Director 1 row
Everyone on file, with contracts and lobbying under the company's name: Medpace Holdings, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 22 | 41 | November 14, 2025 | October 1, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.